Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Am J Transplant. 2014 Apr 17;14(6):1346–1355. doi: 10.1111/ajt.12698

Figure 3.

Figure 3

(A, B) Pharmacodynamic (CD3 absolute/mm3) responses to increasing dosesofTOL101 over 5–9 days. The mean of each cohort is presented.